Home Tags Cancer: Breast

Tag: Cancer: Breast

The combination of digital mammography and digital breast tomosynthesis detects 90 percent more breast cancers than digital mammography alone

Combined Digital Screening Best for Detecting Breast Cancers

Digital mammography and tomosynthesis better than digital mammography alone
The American Society for Clinical Oncology has endorsed the Society for Integrative Oncology guideline on the use of integrative therapies during and after breast cancer treatment

ASCO Endorses SIO Guideline for Integrative Tx in Breast Cancer

Guideline recommends therapies for reducing anxiety/stress, depression/mood disorders, nausea
The C-509T allele in the promoter region of transforming growth factor β is associated with radiation-induced breast fibrosis risk among patients with early-stage breast cancer

TGFB1 Mutation Ups Radiation-Induced Breast Fibrosis Risk

C-509T allele and postoperative cosmetic surgery significantly linked to breast fibrosis risk
Acupuncture may cut joint pain among postmenopausal women with early-stage breast cancer and aromatase inhibitor-related pain

Acupuncture May Cut Arthralgia From Aromatase Inhibitors

Clinical significance of the pain reduction remains uncertain
A magnetic system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy has been approved by the U.S. Food and Drug Administration.

FDA Approves Magnetic System for Guiding Lymph Node Biopsies

Sentimag System uses magnetic detection to identify sentinel lymph nodes for surgical removal
The U.S. Food and Drug Administration has approved ribociclib in combination with an aromatase inhibitor as an initial endocrine-based therapy for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor-positive

FDA Grants First Approval for CA Drug Under New Pilot Programs

Ribociclib approved in combo with AI as endocrine tx for HR-positive, HER2-negative advanced breast CA
Higher levels of vitamin D may be protective against breast cancer

Higher Vitamin D Levels May Lower Breast Cancer Risk

Pooled analysis finds levels ≥60 ng/mL are most protective among women aged 55 years and older
The attending surgeon is associated with variation in the receipt of genetic testing after breast cancer diagnosis

Attending Surgeon Influences Genetic Testing in Breast Cancer

About one-third of surgeon variation explained by patient volume, surgeon attitudes to genetic testing
Risk-stratified breast screening improves the cost-effectiveness of screening

Risk-Stratified Breast Cancer Screening Ups Cost-Effectiveness

Risk-stratified screening can reduce overdiagnosis and maintain benefits of screening
Women with dense breasts have a higher rate of recall

Higher Cancer Rates Confirmed in Women With Dense Breasts

Higher rate of recall, lower sensitivity, larger tumor diameter, and more lymph node-positive disease